Verana Health today announced the launch of its Neurology Qdata, available through Verana Health's real-world evidence service offerings.
Neurology Qdata comprises disease-specific datasets to help power neuroscience research and shape therapeutic strategies. Qdata SMA, the first neurology module to launch, is a real-world de-identified dataset reflective of spinal muscular atrophy (SMA) patients found across healthcare settings.
Following the release of Qdata SMA, Verana Health expects to release additional Neurology Qdata modules for neurological diseases including Parkinson's Disease, multiple sclerosis, Neuromyelitis Optica Spectrum Disorder (NMOSD), and others.
Read more about this new model here.